BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8651907)

  • 41. Inhibition of the glycosylation and alteration in the intracellular trafficking of mucins and other glycoproteins by GalNAcalpha-O-bn in mucosal cell lines: an effect mediated through the intracellular synthesis of complex GalNAcalpha-O-bn oligosaccharides.
    Gouyer V; Leteurtre E; Zanetta JP; Lesuffleur T; Delannoy P; Huet G
    Front Biosci; 2001 Oct; 6():D1235-44. PubMed ID: 11578961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiadhesive character of mucin O-glycans at the apical surface of corneal epithelial cells.
    Sumiyoshi M; Ricciuto J; Tisdale A; Gipson IK; Mantelli F; Argüeso P
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):197-203. PubMed ID: 18172093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.
    Bresalier RS; Niv Y; Byrd JC; Duh QY; Toribara NW; Rockwell RW; Dahiya R; Kim YS
    J Clin Invest; 1991 Mar; 87(3):1037-45. PubMed ID: 1999484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of colorectal carcinoma cells with high metastatic potential.
    Bresalier RS; Boland CR; Kim YS
    Gastroenterology; 1984 Jul; 87(1):115-22. PubMed ID: 6724253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin.
    Capon C; Wieruszeski JM; Lemoine J; Byrd JC; Leffler H; Kim YS
    J Biol Chem; 1997 Dec; 272(51):31957-68. PubMed ID: 9405387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation of MUC1 expression to adhesion of breast cancer cell line MDA-MB-231].
    Lu L; Deng HY; Fan WK
    Ai Zheng; 2004 Nov; 23(11):1294-6. PubMed ID: 15522176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation.
    Huet G; Kim I; de Bolos C; Lo-Guidice JM; Moreau O; Hemon B; Richet C; Delannoy P; Real FX; Degand P
    J Cell Sci; 1995 Mar; 108 ( Pt 3)():1275-85. PubMed ID: 7622610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel adapter protein AP162 connects a sialyl-Le(x)-positive mucin with an apoptotic signal transduction pathway.
    Hartel-Schenk S; Gratchev A; Hanski ML; Ogorek D; Trendelenburg G; Hummel M; Höpfner M; Scherübl H; Zeitz M; Hanski C
    Glycoconj J; 2001; 18(11-12):915-23. PubMed ID: 12820725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-Glycans influence the in vitro adhesive and invasive behaviour of three metastatic cell lines.
    Bironaite D; Nesland JM; Dalen H; Risberg B; Bryne M
    Tumour Biol; 2000; 21(3):165-75. PubMed ID: 10754467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.
    Huet G; Hennebicq-Reig S; de Bolos C; Ulloa F; Lesuffleur T; Barbat A; Carrière V; Kim I; Real FX; Delannoy P; Zweibaum A
    J Cell Biol; 1998 Jun; 141(6):1311-22. PubMed ID: 9628888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of benzyl-N-acetyl-α-galactosaminide on KL-6 mucin expression and invasive properties of a human pancreatic carcinoma cell line.
    Xu HL; Inagaki Y; Wang FS; Kokudo N; Nakata M; Tang W
    Drug Discov Ther; 2008 Oct; 2(5):282-5. PubMed ID: 22504721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain.
    Kalra AV; Campbell RB
    Br J Cancer; 2007 Oct; 97(7):910-8. PubMed ID: 17912239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth.
    Makiguchi Y; Hinoda Y; Imai K
    Jpn J Cancer Res; 1996 May; 87(5):505-11. PubMed ID: 8641988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation.
    Sreejayan N; Wittig BM; von Stillfried N; Hennicke MS; Meyer G; Stieber P; Lamerz R; von Ritter C
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G1043-8. PubMed ID: 11292614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human colon cancer cells express multiple glycoprotein ligands for E-selectin.
    Tomlinson J; Wang JL; Barsky SH; Lee MC; Bischoff J; Nguyen M
    Int J Oncol; 2000 Feb; 16(2):347-53. PubMed ID: 10639580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.
    Brockhausen I
    EMBO Rep; 2006 Jun; 7(6):599-604. PubMed ID: 16741504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The saccharides of the MUC 1 mucin-type glycoprotein, epitectin, produced by H.Ep.2 cells in the presence of aryl-N-acetyl-alpha-galactosaminides.
    DiIulio NA; Bhavanandan VP
    Glycobiology; 1995 Mar; 5(2):195-9. PubMed ID: 7780194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucin glycoproteins in colonic neoplasia.
    Kim YS
    Keio J Med; 1998 Mar; 47(1):10-8. PubMed ID: 9560527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measuring the multifaceted roles of mucin-domain glycoproteins in cancer.
    Riley NM; Wen RM; Bertozzi CR; Brooks JD; Pitteri SJ
    Adv Cancer Res; 2023; 157():83-121. PubMed ID: 36725114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of mucin produced by epithelial cancer cells and its biological significance in cancer tissue].
    Nakada H
    Seikagaku; 2005 Jul; 77(7):642-6. PubMed ID: 16114848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.